Showing 221-230 of 10214 results for "".
Approvals in Psoriasis and Skin Cancer Highlight a Year of Innovation in Skin Disease Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/approvals-in-psoriasis-and-skin-cancer-highlight-a-year-of-innovation-in-skin-disease-management/21069/After periods of low drug approval rates, the last year brought several new agents to market.Reviving the Dream: Correcting Suboptimal Results from Injectable Treatments
https://practicaldermatology.com/topics/general-topics/PD0309_10-php/22864/Skill, patience and meticulous selection of products and injection techniques are pre-requisites for satisfactory correction of a poor outcome from treatment with dermal fillers and botulinum toxin.Lidocaine Shortage: Perspectives, Alternatives, and Pathways Forward
https://practicaldermatology.com/topics/practice-management/lidocaine-shortage-perspectives-alternatives-and-pathways-forward/23949/Supply chain issues, communication barriers, and regulatory inconsistencies cause problems for practitioners and patients.Medical Management of Actinic Keratoses and Non- Melanoma Skin Cancer: Disease Progression and Mechanisms of Action of Therapy
https://practicaldermatology.com/topics/general-topics/medical-management-of-actinic-keratoses-and-non--melanoma-skin-cancer-disease-progression-and-mechanisms-of-action-of-therapy/21553/The approach to treatment may be shifting from targeting the lesions we see to addressing an underlying pathology.Barrier Repair: Where Do We Stand?
https://practicaldermatology.com/topics/general-topics/barrier-repair-where-do-we-stand/21455/An update on skin moisturization and the use of prescription barrier repair agents for atopic dermatitis.The Dermatology Industry: A Status Report
https://practicaldermatology.com/topics/psoriasis/the-dermatology-industry-a-status-report/21072/The two companies that stole the spotlight in 2014 continue to drive industry news in the dermatology space.Saving Medical Dermatology: Biologics and the Future of Patient Care
https://practicaldermatology.com/topics/practice-management/saving-medical-dermatology-biologics-and-the-future-of-patient-care/21211/Although prescription rates lag, biologic agents may hold the key to sustaining the specialty.Mycosis Fungoides: Practical Tips on Specific Therapies
https://practicaldermatology.com/topics/general-topics/mycosis-fungoides-practical-tips-on-specific-therapies/21973/With common sense and knowledge of the therapy being administered, the dermatologist can effectively and safely treat MF patients.PRP: What Dermatologists Should Know
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/prp-what-dermatologists-should-know/20333/Long used in orthopedic medicine and made popular on social media, PRP has science to support its use in dermatology.Optimizing Isotretinoin Treatment: Keys to Successful Prescribing and Management
https://practicaldermatology.com/topics/practice-management/optimizing-isotretinoin-treatment-keys-to-successful-prescribing-and-management/21193/Embraced by the dermatology community, isotretinoin is still considered controversial by some patients. Here are tips on navigating the prescribing process to improve patient comfort and adherence.